Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cencora, Inc. Common Stock
(NY:
COR
)
227.54
UNCHANGED
Streaming Delayed Price
Updated: 5:00 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cencora, Inc. Common Stock
< Previous
1
2
3
4
Next >
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
December 04, 2023
New growth drivers are helping to propel these reliable and steady businesses.
Via
The Motley Fool
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
November 29, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here.
Via
Benzinga
Teva Pharma is the way to play the re-rise of generic drugs
November 28, 2023
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
Via
MarketBeat
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,300 Today
November 21, 2023
Via
Benzinga
How Is The Market Feeling About Cencora?
November 17, 2023
Via
Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
October 31, 2023
Via
Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
October 18, 2023
Via
Benzinga
Peering Into Cencora's Recent Short Interest
October 17, 2023
Via
Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
November 14, 2023
The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode.
Via
InvestorPlace
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
November 09, 2023
From
Cencora
Via
Business Wire
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
Peering Into Cencora's Recent Short Interest
September 29, 2023
Via
Benzinga
$100 Invested In Cencora 20 Years Ago Would Be Worth This Much Today
September 27, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years
September 12, 2023
Via
Benzinga
Obesity And Diabetes Drugs Demand Help Distributor Cencora Propel Revenue In Q3
November 02, 2023
Cencora Inc's (NYSE: COR), formerly AmerisourceBergen Corporation,
Via
Benzinga
Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
November 02, 2023
From
Cencora
Via
Business Wire
Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals
November 01, 2023
McKesson earnings are on tap, with Cencora and Cardinal Health due soon.
Via
Investor's Business Daily
Eli Lilly, McKesson, Novartis Flash Promising Chart Action
October 09, 2023
Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities.
Via
MarketBeat
Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release
October 02, 2023
From
Cencora
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
September 01, 2023
On Friday, 57 companies reached new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.